Advancements in Nanotechnology for Pharmaceutical Taste Masking: A Review on Improving Patient Compliance and Oral Drug Formulations Review Article
Main Article Content
Abstract
Successful pharmacotherapy depends on patient cooperation; however, one of the most enduring barriers to adherence, especially in young or elderly patients, is the taste of oral medications. Since effects can differ based on the formulation, age, and even the route of drug administration, conventional taste-masking techniques have been found to be largely ineffective in practice. The limitations of these conventional approaches are examined in this narrative literature review, which also demonstrates how recent developments in nanotechnology offer much more reliable alternatives for development that do not impede patient acceptance. Nano carriers, including liposomal, nanoemulsions, and polymeric nanoparticles, are the best taste-masking agents because they don't affect the release, solubility, or bioavailability of medications. The technologies also enable targeted or controlled drug delivery and circumvent age-dependent swallowing problems. This review demonstrates how Nanotechnology can challenge oral administration paradigms by combining clinical, formulation, and new research data. In addition, it highlights critical research gaps pertaining to cost-effectiveness, regulatory guidance, and sensory evaluation models that must be filled in order to fully implement an operational framework for integrating these technologies into medical practice.
Article Details
Section

This work is licensed under a Creative Commons Attribution 4.0 International License.
How to Cite
References
1. Solomon A, Patient compliance: a key element in the success or failure of treatment. Medical Research Archives. 2023;11(5):45–50.
2. Mohiuddin AK, Patient compliance: fact or fiction? Innovations in Pharmacy. 2019;10(1):24926.
3. Silva N, Souza P, Santos D, Almeida R, Oliveira L, Compliance with treatment: related issues and insights for pharmacist intervention. International Journal of Pharmacy Practice. 2011;19(4):310–317.
4. Kumar RS, Niharika V, Patient compliance: a milestone in therapy. Journal of Drug Delivery and Therapeutics. 2019;9(2):120–128.
5. Reddy M, Non-compliance in pharmacotherapy. Indian Journal of Psychological Medicine. 2012;34(2):107–109.
6. Karim H, Abbas K, Baloch M, Khan S, Therapeutic compliance in hypertensive patients: a cross-sectional study. Journal of Hypertension. 2023;41(3):205–210.
7. Sukmawati S, Emelda A, Nurfajriani N, Patient compliance patterns on therapeutic success of type 2 diabetes mellitus medication. International Journal of Health & Medical Research. 2023;2(7):163–171.
8. Vysotskaya S, Chernyshev A, Compliance problems in cardiology practice. Tambov Medical Journal. 2024;29(1):58–63.
9. Yoo O, Kim J, Park S, Lee D, The development of a chocolate-based chewable tablet of prednisolone. Pharmaceutics. 2024;16(4):450–458.
10. Xue Q, Tang L, Zhang P, Added syrup as a flavoring to oral midazolam solution improves tolerability in pediatric patients. Drug Design, Development and Therapy. 2022;16(5):1211–1216.
11. Hofmanová J, Mason J, Batchelor H, Sensory aspects of acceptability of bitter-flavored tablets. International Journal of Pharmaceutics. 2020;586(1):119511.
12. Loves R, White S, Davies M, Describing taste changes and their potential impacts on paediatric patients receiving cancer treatments. BMJ Supportive & Palliative Care. 2021;11(2):250–257.
13. Mennella J, Reed D, Roberts R, Age-related differences in bitter taste and efficacy of bitter blockers. PLoS ONE. 2014;9(5):e96365.
14. Peña DE, Morgan J, Howard AK, Pediatric prescribers' knowledge of the Ew Meds™ list and taste masking. Journal of Pediatric Pharmacology and Therapeutics. 2024;29(6):624–629.
15. Ranmal S, Batchelor H, Walsh J, Taste assessment for paediatric drug development: a comparison of bitterness taste aversion in children versus naïve and expert young adult assessors. International Journal of Pharmaceutics. 2023;637:123494.
16. Deng M, Huang W, Li J, Comparison of bitterness intensity between prednisolone and quinine in a human sensory test indicated individual differences in bitter-taste perception. Pharmaceutics. 2022;14(3):210–215.
17. Kreeftmeijer-Vegter A, De Vries S, Van der Veen L, Development and evaluation of age-appropriate film-coated tablets of levamisole for paediatric use (2–18 years). Expert Opinion on Drug Delivery. 2013;10(3):293–300.
18. Sahu T, Meena R, Rajput R, Nanotechnology-based drug delivery system: current strategies and emerging therapeutic potential for medical science. Journal of Drug Delivery Science and Technology. 2021;63(4):102487.
19. Petrović S, Bita B, Barbinta-Patrascu M, Nanoformulations in pharmaceutical and biomedical applications: green perspectives. International Journal of Molecular Sciences. 2024;25(11):5842.
20. Nikalje A, Nanotechnology and its applications in medicine. Medicinal Chemistry. 2015;5(2):1–9.
21. Malik S, Muhammad K, Waheed Y, Emerging applications of nanotechnology in healthcare and medicine. Molecules. 2023;28(18):6624.
22. Ahmad M, Ali S, Ahmad I, Applications of nanotechnology in pharmaceutical development. In: Lipids in Nanotechnology. Elsevier; 2012. p.171–190.
23. Zahin N, Anwar R, Tewari D, Nanoparticles and their biomedical applications in health and diseases: special focus on drug delivery. Environmental Science and Pollution Research. 2019;27(16):19151–19168.
24. Sher EK, Khan M, Iqbal Z, Nanotechnology in medicine revolutionizing drug delivery for cancer and viral infection treatments. International Journal of Pharmaceutics. 2024;660:124345.
25. Liu Y, Li Z, Zhang M, Advances in nanotechnology for enhancing the solubility and bioavailability of poorly soluble drugs. Drug Design, Development and Therapy. 2024;18:1469–1495.
26. Halwani A, Development of pharmaceutical nanomedicines: from the bench to the market. Pharmaceutics. 2022;14(1):106–112.
27. Sridhar R, Lakshminarayanan R, Madhaiyan K, Electrosprayed nanoparticles and electrospun nanofibers based on natural materials: applications in tissue regeneration, drug delivery and pharmaceuticals. Chemical Society Reviews. 2015;44(3):790–814.
28. Vishvakarma V, Sharma R, Gupta M, Role of nanotechnology in taste masking: recent updates. Current Drug Research Reviews. 2022;15(1):1–14.
29. Sahu T, Meena R, Rajput R, Nanotechnology-based drug delivery system: current strategies and emerging therapeutic potential for medical science. Journal of Drug Delivery Science and Technology. 2021;63:102487.
30. Malik S, Muhammad K, Waheed Y, Emerging applications of nanotechnology in healthcare and medicine. Molecules. 2023;28(18):6624.
31. Zahin N, Anwar R, Tewari D, Nanoparticles and their biomedical applications in health and diseases: special focus on drug delivery. Environmental Science and Pollution Research. 2020;27(16):19151–19168.
32. Petrović S, Bita B, Barbinta-Patrascu M, Nanoformulations in pharmaceutical and biomedical applications: green perspectives. International Journal of Molecular Sciences. 2024;25(11):5842.
33. Ahmad MU, Ali SM, Ahmad I, Applications of nanotechnology in pharmaceutical development. In: Lipids in Nanotechnology.Elsevier; 2012:171–190.
34. Liu Y, Li Z, Zhang M, Advances in nanotechnology for enhancing the solubility and bioavailability of poorly soluble drugs. Drug Design, Development and Therapy.2024;18:1469–1495.
35. Halwani AA, Development of pharmaceutical nanomedicines: from the bench to the market. Pharmaceutics. 2022;14(1):106–112.
36. Sher EK, Khan M, Iqbal Z, Nanotechnology in medicine revolutionizing drug delivery for cancer and viral infection treatments. International Journal of Pharmaceutics.2024;660:124345.
37. Vishvakarma V, Sharma R, Gupta M, Role of nanotechnology in taste masking: recent updates. Current Drug Research Reviews. 2023;15(1):1–14.